Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oscient Pharmaceuticals Corp. (OSCI) -- Ignore unavailable to you. Want to Upgrade?

To: Starlight who wrote (534)	1/10/2000 11:04:00 PM
From: Secret_Agent_Man	Respond to of 1154

gene is definitely headed in the right direction...

To: Starlight who wrote (534)	1/11/2000 7:40:00 AM
From: OldAIMGuy	Read Replies (1) \| Respond to of 1154

Hi Betty, I went and checked. I usually only enter one buy or sell order per week. I thought I'd entered a new Sell order for about 5% of my GENE after the last order filled. Alas, I hadn't. What a shame. Now I'll have to sell them at a higher price. :-) Since the method I use is a "proportional control" algorithm, at say $22, it's going to ask me to sell quite a bit more than the 5% minimum order I was supposed to have in the works at $19. I'll post what I get accomplished later today. My GENE account was showing about 450% gross profit as of the end of the year. Yesterday's run should bring that up quite a bit. Anyone see the Incyte CEO on CNBC yesterday afternoon? Their stock also soared on good news. However, I believe it's been up quite a bit most of the year. The "deal" they were discussing was for about $10MM per year in fees for use of their database and an unknown royalty if the research proves worth while. Best regards, Tom